v3.25.1
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Millions
3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Cash Provided by (Used in) Operating Activities    
Net earnings $ 1,077 $ 2,129
Adjustments to reconcile net earnings to operating cash flows:    
Depreciation and amortization 71 65
Deferred income tax provision (benefit) 26 (138)
Unrecognized tax benefit 0 33
Fair value adjustment for NJOY Transaction contingent payments 25 0
(Income) losses from investments in equity securities (143) (295)
Impairment of goodwill 873 0
Cash effects of changes    
Receivables (80) (6)
Inventories (18) (26)
Accounts payable (136) (61)
Income taxes 565 671
Accrued liabilities and other current assets (302) (377)
Accrued settlement charges 678 857
Pension plan contributions (5) (4)
Pension and postretirement, net (20) (29)
Other, net 109 58
Net cash provided by (used in) operating activities 2,720 2,877
Cash Provided by (Used in) Investing Activities    
Capital expenditures (38) (35)
Proceeds from the ABI Transaction [1] 0 2,353
Other, net (5) (2)
Net cash provided by (used in) investing activities (43) 2,316
Cash Provided by (Used in) Financing Activities    
Long-term debt issued 997 0
Long-term debt repaid 0 (1,121)
Repurchase of common stock [2] (326) (2,400)
Dividends paid on common stock (1,730) (1,733)
Other, net (26) (14)
Net cash provided by (used in) financing activities (1,085) (5,268)
Cash, cash equivalents and restricted cash:    
Increase (decrease) 1,592 (75)
Balance at beginning of period 3,158 3,721
Balance at end of period 4,750 $ 3,646
Cash and cash equivalents 4,726  
Restricted cash included in other current assets [3] 1  
Restricted cash included in other assets [3] $ 23  
[1] See Note 6. Investments in Equity Securities.
[2] 2024 includes $360 million (15% of the Repurchase Price) paid in March 2024 related to the ASR transactions. See Note 1. Background and Basis of Presentation.
[3] Restricted cash consisted of cash deposits collateralizing appeal bonds posted by PM USA to obtain stays of judgments pending appeals. See Note 14. Contingencies.